Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 3/2017

17.10.2016 | Rhinology

Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer

verfasst von: Bum Soo Kim, Kyoungjune Pak, Keun-Ik Yi, In Joo Kim, Hwan-Jung Roh, Kyu-Sup Cho

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to investigate the value of parameters assessed with F18-FDG PET/CT in predicting recurrence-free survival (RFS) and disease-specific survival (DSS) in patients with cancer of nasal cavity and paranasal sinus. Thirty-eight patients with cancer of nasal cavity (n = 14) and paranasal sinus (n = 24) who underwent PET/CT prior to curative treatment were enrolled. A volume of interest was placed on PET/CT images covering the entire tumor volume, and the maximum SUV (SUVmax), the mean SUV (SUVmean), and volumetric parameters of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured using thresholds of 40 % of SUVmax. The heterogeneity factor (HF) defined as the derivative of volume-threshold function from 40 to 80 % of SUV thresholds. RFS and DSS were defined as the time from the diagnosis to recurrence and death. Median values of SUVmax, SUVmean, MTV, TLG, and HF were 14.81, 9.16, 25.84, 150.74, and −0.496. SUVmax was higher in patients with advanced stage and nodal metastasis. High MTV and low HF group showed shorter RFS. Cox proportional hazards regression analysis revealed low HF was the only significant predictive factor on RFS. Furthermore, high TLG was associated with shorter DSS. High TLG was potent predictor of DSS by Cox proportional hazards regression analysis. In conclusion, the tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT could be significant prognostic surrogate markers in patients with sinonasal cancer.
Literatur
1.
Zurück zum Zitat Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F (2013) Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 24:39–49CrossRefPubMed Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F (2013) Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 24:39–49CrossRefPubMed
2.
Zurück zum Zitat Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34:877–885CrossRefPubMed Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34:877–885CrossRefPubMed
3.
Zurück zum Zitat Khademi B, Moradi A, Hoseini S, Mohammadianpanah M (2009) Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 13:191–199CrossRefPubMed Khademi B, Moradi A, Hoseini S, Mohammadianpanah M (2009) Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 13:191–199CrossRefPubMed
4.
Zurück zum Zitat Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92:3012–3029CrossRefPubMed Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92:3012–3029CrossRefPubMed
5.
Zurück zum Zitat Cantu G, Bimbi G, Miceli R, Mariani L, Colombo S, Riccio S et al (2008) Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 134:170–177CrossRefPubMed Cantu G, Bimbi G, Miceli R, Mariani L, Colombo S, Riccio S et al (2008) Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 134:170–177CrossRefPubMed
6.
Zurück zum Zitat Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC et al (2015) Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Clin Exp Otorhinolaryngol 8:142–148CrossRefPubMedPubMedCentral Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC et al (2015) Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Clin Exp Otorhinolaryngol 8:142–148CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM et al (2012) 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med 53:709–715CrossRefPubMed Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM et al (2012) 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med 53:709–715CrossRefPubMed
8.
Zurück zum Zitat Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Naganawa S et al (2014) Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer. Ann Nucl Med 28:356–362CrossRefPubMed Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Naganawa S et al (2014) Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer. Ann Nucl Med 28:356–362CrossRefPubMed
9.
Zurück zum Zitat Abgral R, Keromnes N, Robin P, Le Roux PY, Bourhis D, Palard X et al (2014) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667CrossRefPubMed Abgral R, Keromnes N, Robin P, Le Roux PY, Bourhis D, Palard X et al (2014) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667CrossRefPubMed
10.
Zurück zum Zitat Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H et al (2014) FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol 203:W139–W145CrossRefPubMedPubMedCentral Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H et al (2014) FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol 203:W139–W145CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Yang Z, Shi Q, Zhang Y, Pan H, Yao Z, Hu S et al (2015) Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma—a retrospective study. Radiat Oncol 10(1):4CrossRefPubMedPubMedCentral Yang Z, Shi Q, Zhang Y, Pan H, Yao Z, Hu S et al (2015) Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma—a retrospective study. Radiat Oncol 10(1):4CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Miller TR, Grigsby PW (2002) Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53:353–359CrossRefPubMed Miller TR, Grigsby PW (2002) Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53:353–359CrossRefPubMed
13.
Zurück zum Zitat Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945CrossRefPubMed Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945CrossRefPubMed
14.
Zurück zum Zitat Son SH, Kim DH, Hong CM, Kim CY, Jeong SY, Lee SW et al (2014) Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14:585CrossRefPubMedPubMedCentral Son SH, Kim DH, Hong CM, Kim CY, Jeong SY, Lee SW et al (2014) Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14:585CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Huang B, Chan T, Kwong DL, Chan WK, Khong PL (2012) Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am J Roentgenol 199:169–174CrossRefPubMed Huang B, Chan T, Kwong DL, Chan WK, Khong PL (2012) Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am J Roentgenol 199:169–174CrossRefPubMed
16.
Zurück zum Zitat Kidd EA, Grigsby PW (2008) Intratumoral metabolic heterogeneity of cervical cancer. Clin Cancer Res 14:5236–5241CrossRefPubMed Kidd EA, Grigsby PW (2008) Intratumoral metabolic heterogeneity of cervical cancer. Clin Cancer Res 14:5236–5241CrossRefPubMed
17.
Zurück zum Zitat Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42:241–251CrossRefPubMed Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42:241–251CrossRefPubMed
18.
Zurück zum Zitat Soydal C, Yuksel C, Kucuk NO, Okten I, Ozkan E, Doganay Erdogan B (2014) Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in esophageal cancer patients. Mol Imaging Radionucl Ther 23:12–15CrossRefPubMedPubMedCentral Soydal C, Yuksel C, Kucuk NO, Okten I, Ozkan E, Doganay Erdogan B (2014) Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in esophageal cancer patients. Mol Imaging Radionucl Ther 23:12–15CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lee HS, Kim HO, Hong YS, Kim TW, Kim JC, Yu CS et al (2014) Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. J Nucl Med 55:582–589CrossRefPubMed Lee HS, Kim HO, Hong YS, Kim TW, Kim JC, Yu CS et al (2014) Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. J Nucl Med 55:582–589CrossRefPubMed
20.
Zurück zum Zitat Hong SP, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH et al (2014) Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters. Skelet Radiol 43:641–648CrossRef Hong SP, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH et al (2014) Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters. Skelet Radiol 43:641–648CrossRef
21.
Zurück zum Zitat Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D et al (2014) F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. Eur J Haematol 92:382–389CrossRefPubMed Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D et al (2014) F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. Eur J Haematol 92:382–389CrossRefPubMed
22.
Zurück zum Zitat Ramakrishnan VR, Lee JY, O’Malley BW Jr, Palmer JN, Chiu AG (2013) 18-FDG-PET in the initial staging of sinonasal malignancy. Laryngoscope 123:2962–2966CrossRefPubMed Ramakrishnan VR, Lee JY, O’Malley BW Jr, Palmer JN, Chiu AG (2013) 18-FDG-PET in the initial staging of sinonasal malignancy. Laryngoscope 123:2962–2966CrossRefPubMed
23.
Zurück zum Zitat La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74:1335–1341CrossRefPubMedPubMedCentral La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74:1335–1341CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55:884–890CrossRefPubMed Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55:884–890CrossRefPubMed
25.
Zurück zum Zitat van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA et al (2011) Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoral FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38:1636–1647CrossRefPubMedPubMedCentral van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA et al (2011) Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoral FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38:1636–1647CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC et al (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62:545–553CrossRefPubMed Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC et al (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62:545–553CrossRefPubMed
27.
Zurück zum Zitat Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M et al (2005) Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46:675–682PubMed Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M et al (2005) Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46:675–682PubMed
28.
Zurück zum Zitat Kang SR, Song HC, Byun BH, Oh JR, Kim HS, Hong SP et al (2014) Intratumoral metabolic heterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. Nucl Med Mol Imaging 48:16–25CrossRefPubMed Kang SR, Song HC, Byun BH, Oh JR, Kim HS, Hong SP et al (2014) Intratumoral metabolic heterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. Nucl Med Mol Imaging 48:16–25CrossRefPubMed
29.
Zurück zum Zitat Eary JF, O’Sullivan F, O’Sullivan J, Conrad EU (2008) Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 49:1973–1979CrossRefPubMedPubMedCentral Eary JF, O’Sullivan F, O’Sullivan J, Conrad EU (2008) Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 49:1973–1979CrossRefPubMedPubMedCentral
Metadaten
Titel
Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer
verfasst von
Bum Soo Kim
Kyoungjune Pak
Keun-Ik Yi
In Joo Kim
Hwan-Jung Roh
Kyu-Sup Cho
Publikationsdatum
17.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2017
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4346-1

Weitere Artikel der Ausgabe 3/2017

European Archives of Oto-Rhino-Laryngology 3/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.